Chronic Lymphoid Leukemia Bone Marrow CD19+/CD5+ B Cells (Relapsed/Refractory)

Cat.No.: CSC-C4562X

Species: Human

Source: Bone Marrow

Cell Type: B

  • Specification
  • Q & A
  • Customer Review
Cat.No.
CSC-C4562X
Description
Chronic Lymphoid Leukemia-PB-CD19+/CD5+ B cells are isolated from Chronic Lymphoid Leukemia bone marrow mononuclear cells using a direct immunomagnetic CD19+ Micro- Bead labeling system. Available in untreated or relapsed/refractory stages.
CD5 co-expression on Bone Marrow-CD19+ B Cells can be used as a strong indicator of Chronic Lymphoid Leukemia infiltration in the bone marrow. In many untreated or lower-staged Chronic Lymphoid Leukemia cases, the co-expression level of CD5 in Bone Marrow-CD19+ cells is significantly lower than the co-expression level within peripheral blood.
Species
Human
Source
Bone Marrow
Cell Type
B
Disease
Diseased
Storage and Shipping
Store in liquid nitrogen and ship in dry ice.
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

Ask a Question

Write your own review

For research use only. Not for any other purpose.